Enchanced Efficacy and Safety of Genotoxic Therapy By P38 MAPK Modulation
US Application 60/246,912
Filed on 2000-11-07
Filed on 2000-11-07
Virus-like Particles as Unlinked Adjuvants
US Application 60/219,763
Filed on 2000-07-20
Filed on 2000-07-20
HLA-DP Restricted CD4+ T Cell Epitopes From The Cancer Antigen, NY ESO-1
US Application 60/237,107
Filed on 2000-09-29
Filed on 2000-09-29
Non-Phosphorylated Hydrophobic Linker-Containing Cyclic Peptide Inhi- bitors of SH2 Domain Binding to Target Protein, Conjugates Thereof, ..
US Application 60/215,610
Filed on 2000-06-30
Filed on 2000-06-30
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES
US Application 60/213,804
Filed on 2000-06-22
Filed on 2000-06-22
Biologically Active Macrolides, Compositions, and Uses Thereof
US Application 60/220,270
Filed on 2000-07-24
Filed on 2000-07-24
Method and Device for Analysis of Biological Specimens
US Application 60/220,904
Filed on 2000-07-26
Filed on 2000-07-26
Method and Compositions of Defensin-Antigen Fusion Proteins as Vaccines for Tumors and Aids
US Application 60/233,074
Filed on 2000-09-15
Filed on 2000-09-15
Methods And Compositions of Viral Chemokine-Antigen Fusion Proteins As Vaccines for Tumors And Aids
US Application 60/233,067
Filed on 2000-09-15
Filed on 2000-09-15
Methods and Compositions For Inhibiting HIV-Coreceptor Interactions
US Application 60/269,534
Filed on 2001-02-15
Filed on 2001-02-15